- Home
- SW vs HOLX Comparison
SW vs HOLX Comparison
Compare SW & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SW | HOLX |
|---|---|---|
| Founded | 1934 | 1985 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 16.6B |
| IPO Year | N/A | 1990 |
Fundamental Metrics
Financial Performance| Metric | SW | HOLX |
|---|---|---|
| Price | $38.37 | $74.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $53.55 | ★ $79.10 |
| AVG Volume (30 Days) | ★ 5.1M | 2.9M |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | ★ 109.82 | N/A |
| EPS | 1.42 | ★ 2.49 |
| Revenue | ★ $31,138,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $52.96 | $6.72 |
| Revenue Next Year | $2.73 | $5.48 |
| P/E Ratio | ★ $26.84 | $29.92 |
| Revenue Growth | ★ 89.50 | 1.74 |
| 52 Week Low | $32.73 | $51.90 |
| 52 Week High | $56.05 | $75.34 |
Technical Indicators
Market Signals| Indicator | SW | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 48.05 |
| Support Level | $37.53 | $74.19 |
| Resistance Level | $38.35 | $75.03 |
| Average True Range (ATR) | 0.83 | 0.22 |
| MACD | 0.23 | -0.15 |
| Stochastic Oscillator | 90.17 | 23.04 |
Price Performance
Historical ComparisonAbout SW Smurfit WestRock plc Ordinary Shares
Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.